ADMA Biologics Inc - Common Stock — datos financieros trimestrales (NASDAQ:ADMA) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas 50.22 M-19.68 M21.14 M13.29 M35.64 M58.25 M 128.32 M Flujo de caja de las actividades de inversión -2.75 M-4.72 M-2.53 M-14.37 M-276 K2.4 M -14.77 M Flujo de caja de las actividades financieras -31.03 M-7.13 M48 K-27.82 M-9.12 M-10.13 M -47.02 M Flujo de caja libre 50.22 M-19.68 M18.61 M-1.07 M34.36 M55.65 M 107.55 M

Noticias

ADMA vs Intellia Therapeutics: Which Biotech Stock Is a Better Pick Now?

Can Asceniv Help ADMA Navigate the Current IG Market Challenges?

New Strong Sell Stocks for May 26th

Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?

Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?

Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?

El director de ADMA Biologics, Jerrold Grossman, compra 100.125 dólares en acciones

New Strong Sell Stocks for May 14th

La llamada al Valor razonable de ADMA Biologics generó un 50% de ganancia

Informe de resultados de ADMA Biologics del Q1 2026 defrauda expectativas

New Strong Sell Stocks for May 11th

ADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View Down